News
Treatment of postoperative diabetes insipidus should be individualized ... In the immediate postoperative setting, hydrocortisone (50-100 mg intravenously every 8 h) is generally used, which ...
Ordinarily, this is given in the form of high-dose prednisone or equivalent steroids (hydrocortisone or dexamethasone ... In the presence of diabetes insipidus, desmopressin (DDAVP) should ...
2mon
GlobalData on MSNEton secures US patent for diabetes insipidus treatmentEton Pharmaceuticals has secured a patent from the US Patent and Trademark Office (USPTO) for its ET-600 product candidate’s desmopressin oral solution formulation for diabetes insipidus ...
Eton Pharmaceuticals, Inc. announced positive results from its pivotal bioequivalence study of ET-600, a patented oral solution of desmopressin aimed at treating central diabetes insipidus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results